The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab.

Auteurs

Buisseret L, Bareche Y, Venet D, Girard E, Gombos A, Emonts P, Majjaj S, Rouas G, Serra M, Debien V, Agostinetto E, Garaud S, Willard-Gallo K, Larsimont D, Stagg J, Rothé F, Sotiriou C

  • Date de publication

    Mei 2024

  • Type

    Article

  • Tijdschrift

    ESMO Open

  • Naam van de onderzoeker

    GOMBOS ANDREA

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Médecine Oncologique

  • PMID

    38703428

  • DOI

    10.1016/j.esmoop.2024.102964